Article
06 May 2025
Ingredient Source Now Or Pay Later: State Ingredient Bans Bring More Accountability To Distributors And Retailers, Not Just Manufacturers
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
23 Apr 2025
U.S. Department Of Commerce Investigates Possible Tariffs On Pharmaceuticals: Forecasting The Impact And An Opportunity To Comment
Article
04 Apr 2025
HHS Under The Second Trump Administration
Article
11 Mar 2025
Department Of Health And Human Services Seeks To Revise Rulemaking Policies
Article
12 Feb 2025
FDA Finalizes Guidance On Scientific Information On Unapproved Uses (SIUU) Communications
Article
12 Nov 2024
What President-Elect Trump's Victory Means For Healthcare In 2025
Article
14 Aug 2024
Fostering More Access To Medical Devices: FDA's Efforts To Advance Health Equity
Article
23 Jul 2024
Loper Bright's Implications For The Food And Drug Administration And Regulated Industry
Article
15 Jul 2024
Want To Say It Ain't So? FDA Guides Firms On How To Respond To Misinformation
Article
13 Jul 2024
Action Plans On Diversity: Key Requirements For Certain Clinical Studies